Cristina Ivan

Cristina Ivan

UNVERIFIED PROFILE

Are you Cristina Ivan?   Register this Author

Register author
Cristina Ivan

Cristina Ivan

Publications by authors named "Cristina Ivan"

Are you Cristina Ivan?   Register this Author

100Publications

4272Reads

43Profile Views

The non-coding RNome after splenectomy.

J Cell Mol Med 2019 Sep 8. Epub 2019 Sep 8.

Department of Surgery, Fundeni Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.14664DOI Listing
September 2019

Profiling the circulating miRnome reveals a temporal regulation of the bone injury response.

Theranostics 2018 24;8(14):3902-3917. Epub 2018 Jun 24.

i3S - Instituto de Investigação e Inovação em Saúde, INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal.

View Article

Download full-text PDF

Source
http://www.thno.org/v08p3902.htm
Publisher Site
http://dx.doi.org/10.7150/thno.24444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071520PMC
August 2019

Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.

Oncogene 2019 Aug 9;38(33):6095-6108. Epub 2019 Jul 9.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-019-0862-yDOI Listing
August 2019

Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.

J Natl Cancer Inst 2019 May 24. Epub 2019 May 24.

Departments of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djz097DOI Listing
May 2019

EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.

Oncogene 2019 03 19;38(12):2123-2134. Epub 2018 Nov 19.

Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1825 Pressler St., Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41388-018-0565-9
Publisher Site
http://dx.doi.org/10.1038/s41388-018-0565-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579606PMC
March 2019

Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling.

Anticancer Res 2019 Mar;39(3):1105-1118

Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13219DOI Listing
March 2019

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.

EBioMedicine 2019 Feb 14;40:290-304. Epub 2019 Jan 14.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2018.11.045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411965PMC
February 2019

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.

EBioMedicine 2018 Dec 25;38:100-112. Epub 2018 Nov 25.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523964183049
Publisher Site
http://dx.doi.org/10.1016/j.ebiom.2018.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306310PMC
December 2018

Circular RNAs: Methodological challenges and perspectives in cardiovascular diseases.

J Cell Mol Med 2018 11 11;22(11):5176-5187. Epub 2018 Sep 11.

Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.13789DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201346PMC
November 2018

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.

Cancer Lett 2018 08 8;430:47-56. Epub 2018 May 8.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835183032
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2018.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004098PMC
August 2018

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.

Mol Cancer 2018 07 16;17(1):100. Epub 2018 Jul 16.

Department of Biochemistry and Molecular Biology, Stanley S. Scott Cancer Center, LSUHSC School of Medicine, New Orleans, LA, 70112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-018-0851-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048708PMC
July 2018

Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.

Cancer Res 2018 06 6;78(11):2990-3001. Epub 2018 Mar 6.

Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-2319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984683PMC
June 2018

ADH1B promotes mesothelial clearance and ovarian cancer infiltration.

Oncotarget 2018 May 18;9(38):25115-25126. Epub 2018 May 18.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982754PMC
May 2018

Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells.

Front Oncol 2018 9;8. Epub 2018 Feb 9.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811641PMC
February 2018

FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.

Cancer Biol Ther 2018 01 19;19(1):76-86. Epub 2017 Dec 19.

a Department of Thoracic Oncology , Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Chengdu , Sichuan , China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2017.1394541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790345PMC
January 2018

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.

Mol Ther Nucleic Acids 2017 Dec 5;9:251-262. Epub 2017 Jul 5.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omtn.2017.06.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675720PMC
December 2017

Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translation.

PLoS Biol 2017 Sep 29;15(9):e2002623. Epub 2017 Sep 29.

Department of Radiation Oncology Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pbio.2002623DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636171PMC
September 2017

Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections.

EBioMedicine 2017 Jun 19;20:182-192. Epub 2017 Apr 19.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The RNA Interference and Non-Coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2017.04.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478184PMC
June 2017

Baseline Hemodynamic Impairment and Future Stroke Risk in Adult Idiopathic Moyamoya Phenomenon: Results of a Prospective Natural History Study.

Stroke 2017 04 10;48(4):894-899. Epub 2017 Mar 10.

From the Department of Radiology (C.P.D.), Department of Neurology (C.P.D., P.H.D.), and Department of Neurosurgery (C.P.D.), University of Iowa Hospitals and Clinics, Iowa City; Department of Neurological Surgery (G.J.Z., R.L.G., R.G.D.), Department of Neurology (A.R.Z.), Department of Radiology (J.R.S., N.H., L.S., J.J.L., H.J.), and Division of Biostatistics (J.P.M.), Washington University School of Medicine, St Louis, MO; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL (S.P.); Department of Neurology, University of Indiana Medical School, Indianapolis (C.S.I.); and Department of Neurology, University of Texas Southwestern Medical School, Dallas (V.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.116.014538DOI Listing
April 2017

Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells.

Oncotarget 2017 Feb;8(7):10905-10918

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355233PMC
February 2017

MALAT1 promoted invasiveness of gastric adenocarcinoma.

BMC Cancer 2017 01 11;17(1):46. Epub 2017 Jan 11.

Division of Gastroenterology, Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2988-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225525PMC
January 2017

H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.

EBioMedicine 2016 Nov 19;13:113-124. Epub 2016 Oct 19.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2016.10.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264449PMC
November 2016

Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.

Neoplasia 2016 Nov 25;18(11):689-698. Epub 2016 Oct 25.

Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL; Robert H. Lurie Cancer Center, Chicago, IL; Jesse Brown VA Medical Center, Chicago, IL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2016.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094382PMC
November 2016

miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.

J Natl Cancer Inst 2016 08 13;108(8). Epub 2016 Apr 13.

Affiliation of authors: Departments of Experimental Radiation Oncology (BGD, LLa, PD, RAL, ARW, WX, DLS, LLi), Hematopathology (SA, JMR), Experimental Therapeutics (KC, CI, GAC), Pathology (LH, SK), Biostatistics (CW, WW), Radiation Oncology (AB, PKA, TAB, WAW), and Breast Medical Oncology (NTU), The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX (XHZ); Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX (BGD, LLa, SA, LH, RAL, ARW, WX, DLS, LLi, SK, TAB, NTU, JMR, WAW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017951PMC
August 2016

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.

Neuro Oncol 2016 05 11;18(5):639-48. Epub 2015 Dec 11.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas (J.W., E.K.N., L.-Y.K., Y.H., S.X., K.G., X.L., N.H., A.B.H.); Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas (W.Q., S.Z.); Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas (C.I.); Departments of Neuropathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (G.N.F.); Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.R.G.); Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (W.O.); Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas (G.A.C.); Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China (S.X.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827047PMC
May 2016

Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.

Cell Cycle 2015 6;14(14):2265-73. Epub 2015 May 6.

a Department of Molecular and Cellular Oncology ; The University of Texas MD Anderson Cancer Center ; Houston , TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2015.1046655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613181PMC
April 2016

Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.

Clin Cancer Res 2016 Apr 18;22(7):1713-24. Epub 2015 Nov 18.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818718PMC
April 2016

PD-L1 expression and prognostic impact in glioblastoma.

Neuro Oncol 2016 Feb 30;18(2):195-205. Epub 2015 Aug 30.

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (E.K.N., J.W., N.K.Y., N.H., L.-Y.K., K.G., X.L., A.B.H.); Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (S.Z.); Center for RNA Interference and Non-Coding RNAs, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.I.); Flow Cytometry and Cell Imaging Core Facility, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (J.K.B.); Neuropathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (G.N.F.); Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (G.A.C.); Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.A.C.); Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.C., K.R.); Lion Biotechnologies, Woodland Hills, California (J.Q.C., L.R.); Dept. of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida (J.Q.C., L.R.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/early/2015/
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724183PMC
February 2016

PDL1 Regulation by p53 via miR-34.

J Natl Cancer Inst 2016 Jan 17;108(1). Epub 2015 Nov 17.

Departments of Experimental Radiation Oncology (MAC, DV, XW, YY), Experimental Therapeutics (CI, GAC), and Radiation Oncology (RK, DRG, SK, JWW), The University of Texas MD Anderson Cancer Center, Houston, TX; Mirna Therapeutics, Inc., Austin, TX (HJP, KK, DM, AGB); Ohio State University, Columbus, OH (LA, DPC, KS); Texas Veterinary Pathology Associates (Houston), Houston, TX (DKG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862407PMC
January 2016

Role of Increased n-acetylaspartate Levels in Cancer.

J Natl Cancer Inst 2016 Jan 26;108(6):djv426. Epub 2016 Jan 26.

Departments of Gynecologic Oncology and Reproductive Medicine (BZ, RAP, RR, TM, ASN, HJD, WH, CI, SYW, KMG, SP, LSM, AMN, GAP, AKS), Cancer Systems Imaging (NMZ, CRM, PKB), Biostatistics (MG), Cancer Medicine (CVP), Center for RNA Interference and Non-Coding RNA (CI, LSM, CRA, GLB, AKS), Cancer Biology (YS, MBE, GLB, AKS), Experimental Therapeutics (CRA, GLB), Bioinformatics and Computational Biology (YW, KAB), Melanoma Medical Oncology (MAD), and Pathology (JL), University of Texas M. D. Anderson Cancer Center, Houston, TX; Department of Nanomedicine and Bioengineering, UT Health, Houston, TX (GLB, AKS); Departments of Psychology, Urology, and Obstetrics and Gynecology, the University of Iowa, Iowa City, IA (SKL); Laboratory for Systems Biology of Human Diseases (LY, JB, AA, DN), Department of Chemical and Biomolecular Engineering (LY, JB, AA, DN), and Department of Bioengineering (DN), Rice University, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849357PMC
January 2016

Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.

Cell Rep 2015 Dec 10;13(11):2395-2402. Epub 2015 Dec 10.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.11.047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691557PMC
December 2015

Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma.

Am J Cancer Res 2015 15;5(10):3135-48. Epub 2015 Sep 15.

School of Molecular and Cellular Biology, University of Leeds Leeds, LS2 9JT, UK ; Department of Biochemistry and Molecular Biology, University of Texas, M. D. Anderson Cancer Center Unit 1000, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656736PMC
December 2015

Targeting c-MYC in Platinum-Resistant Ovarian Cancer.

Mol Cancer Ther 2015 Oct 30;14(10):2260-9. Epub 2015 Jul 30.

Department of Biochemistry, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico. University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-0801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596776PMC
October 2015

Infarct location and sleep apnea: evaluating the potential association in acute ischemic stroke.

Sleep Med 2015 Oct 17;16(10):1198-203. Epub 2015 Jul 17.

Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; VA HSR&D Center for Health Information and Communication (CHIC), Richard L. Roudebush VA Medical Center, Indianapolis, IN 46202, USA; Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Regenstrief Institute, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sleep.2015.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592521PMC
October 2015

VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells.

Mol Cancer Res 2015 Sep 3;13(9):1274-82. Epub 2015 Jun 3.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-15-0061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573265PMC
September 2015

Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.

J Natl Cancer Inst 2015 Jul 13;107(7). Epub 2015 May 13.

Children's Center for Cancer and Blood Diseases and The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA; and Departments of Pediatrics and Molecular Microbiology & Immunology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA (KBC, PMW, PN, HC, MM, MF); Division of Medical Oncology, Department of Internal Medicine, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles, CA (TX, AG); Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA (RK, MH, AJ, RCS, SA); Departments of Experimental Therapeutics and Leukemia and The Center for RNA interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX (CI, GAC); Department of Gynecologic Oncology and Reproductive Medicine and The Center for RNA interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX (XZ); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) s.r.l., IRCCS, Gene Therapy Unit, Meldola (FC) 47014, Italy (IV, FF, DA); Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA (HS, SA).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651042PMC
July 2015

PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.

Mol Cancer Ther 2015 Jun 1;14(6):1466-1475. Epub 2015 Apr 1.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-1077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458384PMC
June 2015

Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.

EBioMedicine 2015 Jun 29;2(6):572-82. Epub 2015 Apr 29.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-1402, USA ; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2015.04.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535165PMC
June 2015

Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer.

Clin Cancer Res 2015 May 16;21(9):2127-37. Epub 2015 Jan 16.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNAi and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2015/01/
Web Search
http://clincancerres.aacrjournals.org/content/early/2015/03/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-2279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417466PMC
May 2015

TP53 loss creates therapeutic vulnerability in colorectal cancer.

Nature 2015 Apr 22;520(7549):697-701. Epub 2015 Apr 22.

1] Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417759PMC
April 2015

Clinically relevant microRNAs in ovarian cancer.

Mol Cancer Res 2015 Mar 10;13(3):393-401. Epub 2014 Oct 10.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369176PMC
March 2015

Retroperitoneal perirenal myxoid liposarcoma.

J Surg Case Rep 2015 Mar 5;2015(3). Epub 2015 Mar 5.

Urology Department, Cluj-Napoca County Hospital, Cluj Napoca, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jscr/rju127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351451PMC
March 2015

Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.

Oncotarget 2015 Mar;6(9):7262-79

University of Southampton Cancer Sciences Division, Somers Cancer Research Building, Southampton University Hospital NHS Trust, Southampton, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466683PMC
http://dx.doi.org/10.18632/oncotarget.3225DOI Listing
March 2015

Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.

Clin Cancer Res 2015 Jan 21;21(2):448-59. Epub 2014 Nov 21.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2015/01/
Web Search
http://clincancerres.aacrjournals.org/content/early/2014/11/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-1578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297546PMC
January 2015

Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis.

Cancer Cell 2014 Nov 23;26(5):707-21. Epub 2014 Oct 23.

Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2014.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254633PMC
November 2014

Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.

Nat Commun 2014 Oct 29;5:5202. Epub 2014 Oct 29.

1] Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA [2] Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA [3] Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215647PMC
October 2014

The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression.

Cell Rep 2014 Sep 28;8(5):1447-60. Epub 2014 Aug 28.

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2014.07.058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163106PMC
September 2014

Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.

Oncotarget 2014 Sep;5(18):8492-502

Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226699PMC
http://dx.doi.org/10.18632/oncotarget.2329DOI Listing
September 2014

Tumor enucleation with zero ischemia for renal cell carcinoma by robotic retroperitoneal approach.

Urol J 2014 Jul 8;11(3):1721-3. Epub 2014 Jul 8.

Department of Urology, Clinical Municipal Hospital, Cluj Napoca, Romania.

View Article

Download full-text PDF

Source
July 2014

Notch3 pathway alterations in ovarian cancer.

Cancer Res 2014 Jun 17;74(12):3282-93. Epub 2014 Apr 17.

Authors' Affiliations: Departments of Gynecologic Oncology and Reproductive Medicine, Systems Biology, Pathology, Experimental Therapeutics, Bioinformatics and Computational Biology, Cancer Biology, Thoracic/Head and Neck Medical Oncology, and The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TexasAuthors' Affiliations: Departments of Gynecologic Oncology and Reproductive Medicine, Systems Biology, Pathology, Experimental Therapeutics, Bioinformatics and Computational Biology, Cancer Biology, Thoracic/Head and Neck Medical Oncology, and The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TexasAuthors' Affiliations: Departments of Gynecologic Oncology and Reproductive Medicine, Systems Biology, Pathology, Experimental Therapeutics, Bioinformatics and Computational Biology, Cancer Biology, Thoracic/Head and Neck Medical Oncology, and The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-2066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058356PMC
June 2014

Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer.

Clin Cancer Res 2014 Jun 22;20(12):3280-8. Epub 2014 Apr 22.

Authors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, WashingtonAuthors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, WashingtonAuthors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, Washington

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-0445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062703PMC
June 2014

Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis.

Proc Natl Acad Sci U S A 2014 Apr 24;111(14):5331-6. Epub 2014 Mar 24.

Departments of Pharmacology, Obstetrics and Gynecology, and Surgery, and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.1317242111
Publisher Site
http://dx.doi.org/10.1073/pnas.1317242111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986124PMC
April 2014